HARVARD BIOSCIENCE, INC. Business Combination, Consideration Transferred
HARVARD BIOSCIENCE, INC. (HBIO) reported Business Combination, Consideration Transferred of $70.60 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-02.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2019-11-08
- HARVARD BIOSCIENCE, INC. business combination, consideration transferred for the quarter ending 2018-06-30 was $600.00K.
- HARVARD BIOSCIENCE, INC. business combination, consideration transferred for the quarter ending 2018-03-31 was $70.00M.
| Period end | Business Combination, Consideration Transferred | Business Combination, Consideration Transferred as first filed | Business Combination, Consideration Transferred 3 month | Business Combination, Consideration Transferred 6 month |
|---|---|---|---|---|
| 2018-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $70.60M 10-Q · filed 2018-08-02 | ||
| 2018-03-31 | $70.00M 10-Q · filed 2018-05-10 | |||
| 2018-01-31 | $71.10M 10-Q · filed 2019-11-08 | $70.60M 10-Q · filed 2018-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |